Pyruvate sensitizes pancreatic tumors to a hypoxia activated pro-drug TH-302.

J. W. Wojtkowiak, H. C. Cornell, S. Matsumoto, K. Saito, Y. Takakusagi, P. Dutta, M. Kim, X. Zhang, R. Leo, K. M. Bailey, G. Martinez, M. C. Lloyd, R. M. Lynch, A. Baker, R. A. Gatenby, K. Rejniak, C. Hart, M. C. Krishna, R. J. Gillies

Research output: Contribution to journalArticle

Cite this

Pyruvate sensitizes pancreatic tumors to a hypoxia activated pro-drug TH-302. / Wojtkowiak, J. W.; Cornell, H. C.; Matsumoto, S.; Saito, K.; Takakusagi, Y.; Dutta, P.; Kim, M.; Zhang, X.; Leo, R.; Bailey, K. M.; Martinez, G.; Lloyd, M. C.; Lynch, R. M.; Baker, A.; Gatenby, R. A.; Rejniak, K.; Hart, C.; Krishna, M. C.; Gillies, R. J.

In: Cancer Metab., Vol. 3, 29.01.2015, p. 2-15.

Research output: Contribution to journalArticle